Risk to Healthcare-Related Businesses from Delays in Legislation, Permits, and Approvals under the Technical Intern Training Program
First written in FY2018. 5 of 5 entries say "Materialised", first in FY2018. Latest entry: FY2019.
Pole To Win Holdings moved to the "Worse" side of this theme in 2018.
0 other companies' latest entry also says "Materialised".
- FY2019MaterialisedAnnual report
「アイメイド株式会社 had provided medical-related staffing services, including the placement of care workers and certified care workers, as well as educational services, but withdrew from that service and decided to provide only after-sales follow-up services for personnel previously introduced to medical institutions. As a result, revenue from the business was ¥278.174 million, up 26.6% year on year, and the operating loss was ¥213.041 million, compared with a loss of ¥425.007 million in the same period of the previous year. The company recorded a ¥78.171 million loss on business withdrawal as an extraordinary loss.」
The company reports a ¥78.171 million loss on business withdrawal and a full-year operating loss in the medical-related business as the impact of withdrawing from the educational services business amid delays in legal development and licensing. - FY2019-Q3MaterialisedAnnual report
「As one of its businesses, the company had provided educational services to users of the Technical Intern Training Program for Foreigners, but withdrew from that service because legal development and licensing in the relevant countries had been delayed. Going forward, it decided to provide only after-sales follow-up services for personnel previously introduced to medical institutions. As a result, revenue from the medical-related business was ¥132.480 million, down 52.6% year on year, and the operating loss was ¥245.214 million, compared with a loss of ¥121.096 million in the same period of the previous year. The company recorded a ¥77.370 million loss on business withdrawal as an extraordinary loss.」
The company states that it withdrew from the educational services business because of delays in legal development and licensing, resulting in lower revenue, an operating loss and a loss on business withdrawal. - FY2019-Q2MaterialisedAnnual report
「アイメイド株式会社 provides medical-related staffing services, including the placement of care workers and certified care workers, as well as educational services. As one of its businesses, it provided educational services to users of the Technical Intern Training Program for Foreigners, but decided to withdraw from that service because legal development and licensing in the relevant countries had been delayed. As a result, revenue from the medical-related business was ¥110.110 million, down 33.2% year on year, and the operating loss was ¥214.021 million, compared with a loss of ¥125.618 million in the same period of the previous year. The company recorded a ¥71.970 million loss on business withdrawal as an extraordinary loss.」
Following delays in legal development and licensing in the relevant countries, the company decided to withdraw from educational services for users of the Technical Intern Training Program for Foreigners, resulting in lower revenue, an operating loss and a loss on business withdrawal. - FY2019-Q1MaterialisedAnnual report
「Due to delays in legislation and licensing in the relevant countries concerning the Technical Intern Training Program for foreign nationals, net sales in this business were ¥71 million, up 19.1% year on year, and operating loss was ¥96 million, compared with a loss of ¥66 million in the same period of the previous year.」
Delays in legal development and licensing in the relevant countries continued to be cited as a factor behind the medical-related business's operating loss, which widened from the same period of the previous year. - FY2018MaterialisedAnnual report
「After provisions were recorded against losses arising from delays in legislation and licensing in the relevant countries concerning the Technical Intern Training Program for foreign nationals, net sales in this business were ¥116 million, down 59.9% year on year, and operating loss was ¥422 million, compared with a loss of ¥60 million in the same period of the previous year.」
The company recorded provisions against delays in legislation and licensing in the relevant countries, and states that the impact materialised as lower sales and a wider operating loss in the healthcare-related business.